Oxidative Medicine and Cellular Longevity

Vanadium Toxicological Potential versus Its Pharmacological Activity: New Developments and Research


Status
Published

1John Paul II Catholic University of Lublin, Lublin, Poland

2Facultad de Estudios Superiores Zaragoza, Mexico, Mexico

3Old Dominion University, Norfolk, USA

4University of Granada, Granada, Spain


Vanadium Toxicological Potential versus Its Pharmacological Activity: New Developments and Research

Description

Vanadium (V) is an element that arouses interest of many research centers worldwide. The dual character of this metal, its multilevel actions, and the level of the complexity of its chemistry are well known. Due to its unique features, vanadium receives a great deal of attention from chemists, biologists, biochemists, toxicologists, and pharmacologists. As a biologically essential redox-active metal, it exhibits very specific behavior and it is able to evoke diametrically opposite effects. It may act as an antioxidant or as a strong prooxidant and attenuate the antioxidant defense system consequently leading to disturbance in the prooxidative-antioxidative balance called oxidative stress being an important aspect of toxicology.

One of the key areas of interest is the medicinal potential of vanadium-containing compounds and their feasible application in specific metallopharmaceutical design. Many scientists seek vanadium-based complexes in the hope of using them against world's threatening diseases, that is, some tropical diseases, and against cancer or diabetes, which are still rising. The range of applications of vanadium compounds in medicine is constantly expanding and numerous studies of the activity of complexes of this element have demonstrated promising results referring to their potential usage in medicine. On the other hand, the possibility of using vanadium-containing compounds as potent pharmacologically active agents redirected researchers’ attention to the toxicological potential of this metal and its possible side effects.

Therefore, further studies are still required to fully understand and elucidate the toxicology as well as the biological and pharmacological activity of vanadium and to determine its toxicity and therapeutic intervals. It is also important to recognize the relationships between the structure and activity of novel potent vanadium complexes as well as to identify gaps in knowledge, which would lead to better understanding of the modes of action and mechanisms of transport of vanadium-based compounds. This may help to estimate the balance between adverse effects of vanadium and its potential therapeutic properties and thereby better develop possible procedures of treatment of the illnesses. Taking the above into account, we invite investigators to submit original research and review articles about selected aspects of vanadium action.

Potential topics include, but are not limited to:

  • Design and pharmacological evaluation of novel vanadium-containing compounds as the next potentially efficient insulin-like agents (synthesis, characterization, structure analysis, mechanisms of action, in vitro and/or in vivo effects, and implications for clinical use)
  • Current progress for development of the vanadium anticancer action: new good candidates showing the medicinal potential in antitumor treatment (synthesis, characterization, structure analysis, possible mode of action, and the most promising evidence demonstrated in the in vitro and/or in vivo studies)
  • Vanadium-containing complexes with the most promising antiparasitic, antiviral, and antimicrobial activity, possible to be used as vanadium-based drugs in the future (synthesis, characterization, structure analysis, possible mechanisms of action, in vitro and/or in vivo effects, and implications for clinical use)
  • Limitations in the usage of vanadium-containing complexes in therapeutic applications
  • A summary of the current knowledge referring to the toxicology of vanadium including, inter alia, the mechanisms and some aspects of genetic and reproductive toxicology on the basis of the research obtained from biological models
  • New perspectives in vanadium research

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 7612347
  • - Editorial

Vanadium Toxicological Potential versus Its Pharmacological Activity: New Developments and Research

Agnieszka Ścibior | Juan Llopis | ... | Mario Altamirano-Lozano
  • Special Issue
  • - Volume 2016
  • - Article ID 6797851
  • - Research Article

In Vivo Effects of Vanadium Pentoxide and Antioxidants (Ascorbic Acid and Alpha-Tocopherol) on Apoptotic, Cytotoxic, and Genotoxic Damage in Peripheral Blood of Mice

María del Carmen García-Rodríguez | Lourdes Montserrat Hernández-Cortés | Mario Agustín Altamirano-Lozano
  • Special Issue
  • - Volume 2016
  • - Article ID 4013639
  • - Review Article

Role of Vanadium in Cellular and Molecular Immunology: Association with Immune-Related Inflammation and Pharmacotoxicology Mechanisms

Olga Tsave | Savvas Petanidis | ... | Athanasios Salifoglou
  • Special Issue
  • - Volume 2016
  • - Article ID 6058705
  • - Research Article

Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus

Samuel Treviño | Denisse Velázquez-Vázquez | ... | Enrique González-Vergara
  • Special Issue
  • - Volume 2016
  • - Article ID 9025627
  • - Research Article

Studies of the Effectiveness of Bisphosphonate and Vanadium-Bisphosphonate Compounds In Vitro against Axenic Leishmania tarentolae

Amy T. Christensen | Craig C. McLauchlan | ... | Marjorie A. Jones
  • Special Issue
  • - Volume 2016
  • - Article ID 6103457
  • - Review Article

Decavanadate Toxicology and Pharmacological Activities: V10 or V1, Both or None?

M. Aureliano
  • Special Issue
  • - Volume 2016
  • - Article ID 4860582
  • - Research Article

Memory Deficit Recovery after Chronic Vanadium Exposure in Mice

Oluwabusayo Folarin | Funmilayo Olopade | ... | James Olopade
Oxidative Medicine and Cellular Longevity
 Journal metrics
Acceptance rate48%
Submission to final decision56 days
Acceptance to publication37 days
CiteScore7.300
Impact Factor5.076
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.